Cargando…

Lexical diversity in Parkinson’s disease

BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative syndrome of the basal ganglia (BG) believed to disrupt cortical-subcortical pathways critical to motor, cognitive and expressive language function. Recent studies have shown subtle deficits in expressive language performance among individua...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Charles, Holt, Yolanda F, West, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710975/
https://www.ncbi.nlm.nih.gov/pubmed/26788341
http://dx.doi.org/10.1186/s40734-015-0017-4
_version_ 1782409891998072832
author Ellis, Charles
Holt, Yolanda F
West, Thomas
author_facet Ellis, Charles
Holt, Yolanda F
West, Thomas
author_sort Ellis, Charles
collection PubMed
description BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative syndrome of the basal ganglia (BG) believed to disrupt cortical-subcortical pathways critical to motor, cognitive and expressive language function. Recent studies have shown subtle deficits in expressive language performance among individuals with PD even in the earliest stage of the disease. The objective of this study was to use measures of lexical diversity to examine expressive language performance during discourse production in a sample of individuals with PD. METHODS: Twelve individuals with idiopathic Parkinson’s disease (PD) were compared to twelve matched, neurologically intact controls on measures of lexical diversity. Three minute discourse samples describing a typical day were collected and analyzed for lexical diversity with the CHILDES program using measures of type token ratio (TTR) and voc-D (D). RESULTS: Comparisons of three minute discourse samples indicated non-significant differences between individuals with PD and controls in word productivity (387 vs 356; p = .48). Similarly, there were also non-significant differences on measures of lexical diversity between the two groups (TTR = .45 vs.44; p = .50 and D 74 vs 68; p = .23). CONCLUSIONS: These results suggest that lexical diversity during discourse production among individuals with PD is similar to non-neurological controls. These findings indicate that lexical diversity is an aspect of expressive language performance that is not impacted by the disease process in the earliest stages.
format Online
Article
Text
id pubmed-4710975
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47109752016-01-19 Lexical diversity in Parkinson’s disease Ellis, Charles Holt, Yolanda F West, Thomas J Clin Mov Disord Research Article BACKGROUND: Parkinson’s disease (PD) is a neurodegenerative syndrome of the basal ganglia (BG) believed to disrupt cortical-subcortical pathways critical to motor, cognitive and expressive language function. Recent studies have shown subtle deficits in expressive language performance among individuals with PD even in the earliest stage of the disease. The objective of this study was to use measures of lexical diversity to examine expressive language performance during discourse production in a sample of individuals with PD. METHODS: Twelve individuals with idiopathic Parkinson’s disease (PD) were compared to twelve matched, neurologically intact controls on measures of lexical diversity. Three minute discourse samples describing a typical day were collected and analyzed for lexical diversity with the CHILDES program using measures of type token ratio (TTR) and voc-D (D). RESULTS: Comparisons of three minute discourse samples indicated non-significant differences between individuals with PD and controls in word productivity (387 vs 356; p = .48). Similarly, there were also non-significant differences on measures of lexical diversity between the two groups (TTR = .45 vs.44; p = .50 and D 74 vs 68; p = .23). CONCLUSIONS: These results suggest that lexical diversity during discourse production among individuals with PD is similar to non-neurological controls. These findings indicate that lexical diversity is an aspect of expressive language performance that is not impacted by the disease process in the earliest stages. BioMed Central 2015-03-02 /pmc/articles/PMC4710975/ /pubmed/26788341 http://dx.doi.org/10.1186/s40734-015-0017-4 Text en © Ellis et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ellis, Charles
Holt, Yolanda F
West, Thomas
Lexical diversity in Parkinson’s disease
title Lexical diversity in Parkinson’s disease
title_full Lexical diversity in Parkinson’s disease
title_fullStr Lexical diversity in Parkinson’s disease
title_full_unstemmed Lexical diversity in Parkinson’s disease
title_short Lexical diversity in Parkinson’s disease
title_sort lexical diversity in parkinson’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710975/
https://www.ncbi.nlm.nih.gov/pubmed/26788341
http://dx.doi.org/10.1186/s40734-015-0017-4
work_keys_str_mv AT ellischarles lexicaldiversityinparkinsonsdisease
AT holtyolandaf lexicaldiversityinparkinsonsdisease
AT westthomas lexicaldiversityinparkinsonsdisease